Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference

Journal of Cellular Physiology
Jie ChenYueran Zhao

Abstract

High-mobility group box 1 (HMGB1), a nuclear and extracellular protein, is implicated in the development and progression of some types of cancers. However, no information is available to date regarding the function of HMGB1 in ovarian cancer. In this study, we performed cDNA microarray analysis and identified HMGB1 as a gene dramatically elevated in the highly invasive subclone S1 compared with the low invasive subclone S21 derived from the same cell line SKOV3. Then lentivirus vector with HMGB1 shRNA was constructed and infected the highly invasive cell line S1, A1, and HO8910PM. Real-time RT-PCR, Western blot, and IHC results confirmed the down-regulation of HMGB1 expression by its shRNA was about 80-90% at both the mRNA and protein levels. Knockdown of HMGB1 significantly suppressed ovarian cancer cell proliferation and induced cell cycle arrest at the G1/G0 phase, which was accompanied by decreased expressions of cyclin D1 and PCNA. Furthermore, knockdown of HMGB1 induced ovarian cancer cell apoptosis, which was mediated by increased expression of Bax and decreased expression of Bcl-2. Finally, knockdown of HMGB1 significantly inhibited ovarian cancer cell invasion and metastasis, which was regulated by decreased expression...Continue Reading

References

Feb 11, 1989·Nucleic Acids Research·L WenG R Reeck
May 5, 1986·Biochimica Et Biophysica Acta·J BernuésE Querol
May 22, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Marie-Luise BrezniceanuMartin Zörnig
Jun 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ingrid E DumitriuPatrizia Rovere-Querini
Sep 14, 2006·Journal of Leukocyte Biology·Norimasa ItoMichael T Lotze
May 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jessica E EllermanMichael T Lotze
Jul 5, 2008·Current Opinion in Immunology·Lara CampanaPatrizia Rovere-Querini
Aug 30, 2008·Cellular and Molecular Life Sciences : CMLS·S N Naryzhny
Oct 10, 2008·Annual Review of Pathology·Kathleen R Cho, Ie-Ming Shih
Dec 24, 2008·Journal of Cancer Research and Clinical Oncology·Jie ChenMaosun Fu
May 23, 2009·Nature Reviews. Cancer·Robert C BastGordon B Mills
Jun 19, 2009·Respiratory Medicine·Guan-Hong ShangDian-Jie Lin
Nov 10, 2009·Journal of Cancer Research and Clinical Oncology·Xingjun YaoGuojin Liu
Nov 26, 2009·American Journal of Respiratory Cell and Molecular Biology·Po-Len LiuInn-Wen Chong
Dec 2, 2009·Biochimica Et Biophysica Acta·Huan Yang, Kevin J Tracey
Feb 4, 2010·Biochimica Et Biophysica Acta·Daolin TangMichael T Lotze
Mar 3, 2010·Annual Review of Immunology·Gary P SimsAnthony J Coyle
Mar 30, 2010·Cytokine·Wenchang HuangLei Li
Jun 29, 2010·World Journal of Surgical Oncology·Guoqiang BaoXianli He
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Jan 5, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Biyun QianKexin Chen
Jan 5, 2011·Frontiers in Bioscience (Landmark Edition)·Sungha ParkChi Young Shim
Mar 19, 2011·Cell Death and Differentiation·P N Kelly, A Strasser
Mar 26, 2011·Science·Christine L Chaffer, Robert A Weinberg
Jun 7, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yaping XuShenglin Ma

❮ Previous
Next ❯

Citations

Aug 15, 2013·Archives of Dermatological Research·Kelly E JohnsonTraci A Wilgus
Jun 26, 2013·Immunology and Cell Biology·Kerrilyn R DienerJohn D Hayball
Apr 11, 2014·Hormones & Cancer·Madhuwanti SrinivasanGnanasekar Munirathinam
Mar 1, 2016·International Journal of Biological Macromolecules·Neelam LohaniR Rajeswari Moganty
Dec 19, 2015·Oxidative Medicine and Cellular Longevity·Aida Barreiro-AlonsoM Esperanza Cerdán
Aug 30, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Qingbing MengMinqian Zheng
Apr 5, 2016·Asian Pacific Journal of Cancer Prevention : APJCP·Barbara BukowskaAgnieszka Marczak
Mar 24, 2018·BioMed Research International·Xiaojin WuDongsheng Pei
Sep 25, 2020·Asia-Pacific Journal of Clinical Oncology·Rana Muhammad UsmanFaiz Anwer
Apr 4, 2021·International Journal of Molecular Sciences·Guifeng WangShosuke Kawanishi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.